Headquartered in New Delhi, India, Bagla Group stands as a trailblazer of innovation in the packaging industry. With nearly four decades of experience, Bagla Group has established itself as a pioneer in the adhesive tapes, tear tapes, and POF Shrink Films categories. We cater to a diversified set of geographies and end-markets, ensuring our products reach a global audience. Our journey began with a commitment to quality and innovation, and over the years, we have continually refined our processes to meet the evolving needs of our customers. Our approach to innovation is not just about creating new products; it’s about improving existing ones and finding better ways to serve our customers. This relentless pursuit of innovation has led us to invest heavily in R&D, ensuring that we stay ahead of industry trends and continuously improve our product offerings. Our extensive portfolio includes paper and film-based pressure-sensitive and water-activated tapes, a variety of industrial tapes, tear tape solutions, and POF Shrink Films. Our cutting-edge infrastructure includes six state-of-the-art manufacturing facilities in India. These facilities are equipped with the latest technology and machinery, enabling us to produce high-quality products that meet the diverse needs of our customers. With over 500 SKUs in 50+ product categories, we offer a wide range of solutions to cater to various applications and industries.In recent years, we have invested in new technologies that ultimately lead to a lower carbon footprint. Sustainability is no longer just a goal; it drives our every effort. We are committed to developing eco-friendly products that not only meet the needs of our customers but also contribute to a healthier planet. Our sustainable practices are integrated into every aspect of our operations, from manufacturing to product design and distribution.At Bagla Group, we are proud of our legacy and excited about our future. Our commitment to innovation, sustainability, and customer satisfaction drives us to continuously improve and evolve. With our extensive experience, state-of-the-art infrastructure, and customer-centric approach, we are well-positioned to meet the challenges of the packaging industry and deliver solutions that make a difference. | Bagla Group specializes in the manufacturing of Thermoforming Films, POF Shrink Films, Tear Tapes, Packaging Tapes, and various other packaging products.In the last 38 years, we have supplied products worth more than 400 Million USD to over 2,000 customers in 50 countries across 6 continents.With 7 factories across India, Indonesia and Paraguay and 2 warehouses in USA and Europe supported by 16 international sales offices we provide more than 500 SKUs in over 50 product categories.Along with Six Sigma and over 100 internal quality check points across all processes, our factories are certified by BRC, FDA, ISO and many other international bodies. | Bagla Group specializes in the manufacturing of Thermoforming Films, POF Shrink Films, Tear Tapes, Adhesive Tapes, and various other packaging products.In the last 38 years, we have supplied products worth more than 400 Million USD to over 2,000 customers in 50 countries across 6 continents.With 7 factories across India, Indonesia and Paraguay and 2 warehouses in USA and Europe supported by 16 international sales offices we provide more than 500 SKUs in over 50 product categories.Along with Six Sigma and over 100 internal quality check points across all processes, our factories are certified by BRC, FDA, ISO and many other international bodies.
Aurolab
Aurolab, based in southern part of India, is an integral part of the Aravind Eye Care System. It manufactures a wide range of high quality ophthalmic consumables such as intraocular lenses, surgical sutures, pharmaceutical products, surgical blades and equipments.
AURIGENE PHARMACEUTICAL SERVICES LIMITED
Aurigene Pharmaceutical Services Limited is a leading contract research, development, and manufacturing organization (CRO/CDMO) and a long-term partner providing end-to-end solutions thereby accelerating innovation. With a strong legacy of services in discovery chemistry, discovery biology, development and manufacturing we are ideally positioned to serve global pharma and specialty companies worldwide by providing truly integrated services. We handle both small molecule and large-molecule services across various complex technology platforms and niche technologies. We have access to FDA-inspected dedicated R and D centers in India and cGMP sites across India, UK and Mexico. Beyond science, our operations are rooted in the fundamental principles of compliance, information security, quality and sustainability. | Aurigene Pharmaceutical Services is leading contract research, development, and manufacturing organization (CDMO). Built on the legacy of accelerating innovation and backed by a vast experience in drug discovery and development our mission is to relentlessly work for the success of our clients and to build long term relationships through a holistic approach to accelerate the journey of a molecule from laboratory to market. By providing access to our resources, knowledge and experience, we create success for our clients and ultimately patients. We offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development and manufacturing for clinical phase I-III programs, regulatory submission batches and commercial manufacturing. A differentiating factor is the integrated API and formulations service that spans from key starting material, advanced intermediates, APIs to finished products such as oral solids, sterile products, nasal solutions etc. Our development services in India are complemented by cGMP commercial manufacturing facilities in the UK, Mexico, USA and India.
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB)
AIC-CCMB is a premier life-science incubator based in the Pharma Hub of India, Hyderabad. We offer 20,000 square feet of affordable lab and office space, as well as state-of-the-art equipment, scientific services, training, and mentoring, and provide access to a network of professional advisors for entrepreneurs in the life-sciences and healthcare domain. By creating an incubator environment that fosters innovation and growth, AIC-CCMB helps these companies to succeed and contribute to economic development in the community. The incubator is promoted by CCMB, a vibrant institute, engaged in molecular, structural, and genomic biology (http://CCMB.RES.IN). We are focused primarily on lead-stage and product-stage startups and support them by bringing in experts in regulatory, clinical and marketing needs in addition to connecting them to investors. Established with the support of Atal Innovation Mission (AIM) of the National Institution for Transforming India (NITI Aayog), Government of India at CSIR — CCMB, we are dedicated to improving the quality of life for all. With a footprint in medtech, biopharma, animal health and biodiversity conservation, we believe in industry-academia collaboration for One Health, One World.